Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
Public ClinicalTrials.gov record NCT05383209. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Prospective, Double-masked, Parallel Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Sham for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A prospective, randomized, double-masked study that evaluated the ocular efficacy and safety of two doses of the EYP-1901 intravitreal (IVT) insert compared to sham.
Study identification
- NCT ID
- NCT05383209
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 77 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 28, 2022 (Actual)
- Primary completion
- Feb 12, 2024 (Actual)
- Completion
- May 6, 2024 (Actual)
- Last update posted
- Aug 15, 2025
2022 – 2024
United States locations
- U.S. sites
- 36
- U.S. states
- 19
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| EyePoint Investigative Site | Phoenix | Arizona | 85020 | — |
| EyePoint Investigative Site | Huntington Beach | California | 92647 | — |
| EyePoint Investigative Site | Oxnard | California | 93036 | — |
| EyePoint Investigative Site | Palm Desert | California | 92211 | — |
| EyePoint Investigative Site | Pasadena | California | 90041 | — |
| EyePoint Investigative Site | Poway | California | 92064 | — |
| EyePoint Investigative Site | Sacramento | California | 95825 | — |
| EyePoint Investigative Site | Danbury | Connecticut | 06810 | — |
| EyePoint Investigative Site | Clearwater | Florida | 33761 | — |
| EyePoint Investigative Site | Melbourne | Florida | 32901 | — |
| EyePoint Investigative Site | Miami | Florida | 33143 | — |
| EyePoint Investigative Site | Winter Haven | Florida | 33880 | — |
| EyePoint Investigative Site | Lemont | Illinois | 60439 | — |
| EyePoint Investigative Site | Indianapolis | Indiana | 46290 | — |
| EyePoint Investigative Site | Lenexa | Kansas | 66215 | — |
| EyePoint Investigative Site | Baltimore | Maryland | 21209 | — |
| EyePoint Investigative Site | Hagerstown | Maryland | 21740 | — |
| EyePoint Investigative Site | Springfield | Massachusetts | 01107 | — |
| EyePoint Investigative Site | Reno | Nevada | 89502 | — |
| EyePoint Investigative Site | Bloomfield | New Jersey | 07003 | — |
| EyePoint Investigative Site | Toms River | New Jersey | 08755 | — |
| EyePoint Investigative Site | Great Neck | New York | 11021 | — |
| EyePoint Investigative Site | Erie | Pennsylvania | 16501 | — |
| EyePoint Investigative Site | Florence | South Carolina | 29501 | — |
| EyePoint Investigative Site | Ladson | South Carolina | 29456 | — |
| EyePoint Investigative Site | Rapid City | South Dakota | 57701 | — |
| EyePoint Investigative Site | Germantown | Tennessee | 38138 | — |
| EyePoint Investigative Site | Abilene | Texas | 79606 | — |
| EyePoint Investigative Site | Austin | Texas | 78705 | — |
| EyePoint Investigative Site | Houston | Texas | 78240 | — |
| EyePoint Investigative Site | McAllen | Texas | 78503 | — |
| EyePoint Investigative Site | Plano | Texas | 75075 | — |
| EyePoint Investigative Site | San Antonio | Texas | 78247 | — |
| EyePoint Investigative Site | The Woodlands | Texas | 77384 | — |
| EyePoint Investigative Site | Lynchburg | Virginia | 24502 | — |
| EyePoint Investigative Site | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05383209, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05383209 live on ClinicalTrials.gov.